Navigation Links
Biotech Finishes on a High in August, Burrill Report Says
Date:9/4/2007

SAN FRANCISCO, Sept. 4 /PRNewswire/ -- "Biotech rode a surging market in the final trading days on the capital markets before the Labor Day holiday weekend," said G. Steven Burrill, CEO, Burrill & Company, a San Francisco based global leader in life sciences whose principal activities are in Venture Capital, Merchant Banking and Media. "The Burrill Biotech Select Index closed the month up 4.4% well ahead of the Dow's 1% gain and NASDAQ's 2% increase."

Driving the Burrill Biotech Select Index were Onyx Pharmaceuticals (up 42%) and Vertex Pharmaceuticals (up 21%). Onyx' jump was based on positive clinical data, while Vertex continued its upward climb as investors continue to bet that telaprevir, the company's experimental hepatitis C drug, will become a blockbuster. Amgen's woes continued and in the wake of health concerns surrounding its anemia drugs, Aranesp and Epogen, announced that it would shed 12-14% of its employees and cancel nearly $2 billion worth of capital projects. The company's shares closed down 7% for August and are down 27% year-to-date. It was not so long ago that industry heavyweights Amgen and Genentech were flirting with market caps of $100 billion. At the end of August, Amgen's market cap stood at $54 billion and Genentech's market cap was $79 billion.

It was a very turbulent month to say the least with wild swings in the capital markets with investors being spooked by weak economic data and ongoing credit concerns. "We haven't seen this kind of volatility since 2002," added Burrill. "At this time five years ago biotech was at its lowest point and since then has been on a steady upward climb driven in large part by biotech's blue chip companies. Our analysis, in the Burrill Biotechnology Monthly Report, reveals that an investment in biotech at that time would have yielded a very healthy 13% CAGR return so far.

"In addition, the biotech industry is transitioning from one focused principally on treating sickness to one tha
'/>"/>

SOURCE Burrill & Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Biotechnology industry expected to grow into a three billion dollar industry by 2002
2. Biotechnology on the lead
3. Panacea Biotech To Market Anthrax Vaccine
4. Commercialization of Biotech Discoveries, An Encouragement For Researchers
5. Biotech drug causing anemia-EPREX
6. Leading Biotech Companies Are Interested In Acquisition Of Smaller Companies
7. Biologicals Transfer Proposal between US and Indian Biotechnology
8. Finland and India to interact and cooperate in the filed of telemedicine and biotechnology
9. Vical Biotech and NIH jointly develops HIV vaccine
10. Biotechnology Initiatives Planned In Hyderabad
11. Biotech Osiris to go public
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... San Diego School of Medicine report that older women, ... major loss are more likely to be compassionate toward ... published in this month,s issue of the International ... are associated with better health and well-being as we ... improve the outcomes of individuals whose deficits in compassion ...
(Date:4/17/2014)... the April issue of Immunity , Kevin J. ... Research, says it,s time to take a fresh look ... sepsis, which kills millions worldwide every year, including more ... into the bloodstream to fight an injury or infection ... maintaining good health without inflammation, wounds and infections ...
(Date:4/17/2014)... A Northwestern University synthetic biology team has created ... create programmable therapeutics that could travel the body ... disease. , Engineering cell-based, biological devices that monitor ... in clinical synthetic biology. However, no existing technology ... a patient,s physiological state and respond in a ...
(Date:4/17/2014)... MAYWOOD, Il. (April 17, 2014) Doctors who ... disease called lymphangioleiomyomatosis (LAM) can face an agonizing ... progression of the disease and help relieve shortness ... lung transplants, and sirolimus can cause potentially fatal ... said pulmonologist Dr. Daniel Dilling, medical director of ...
(Date:4/17/2014)... NY (April 16, 2014) The cause of neuronal ... new study proposes that neurons may be mistaken for ... system, similar to the way autoimmune diseases like type ... body,s cells. The study was published April 16, 2014, ... new, and likely controversial, idea in Parkinson,s disease; but ...
Breaking Medicine News(10 mins):Health News:The ilk of human kindness 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Building 'smart' cell-based therapies 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:Is Parkinson's an autoimmune disease? 2
... international study involving researchers from the Sahlgrenska Academy at ... revealed that aspirin, statins, beta blockers and ACE inhibitors ... medicines that could prevent a huge number of deaths ... of a research collaboration between 17 countries, the study ...
... over the past three decades should inspire a new worldwide ... public health leaders. A UN summit will offer a rare ... these diseases. In a perspective article in this week,s ... cite the need for a collective global effort to stem ...
... Gordon HealthDay Reporter , WEDNESDAY, Sept. 7 (HealthDay ... a risk factor for death among black women, according to ... is, the greater her risk of dying sooner than her ... with rising body mass index (BMI). Once women were above ...
... Gonzalez-Guarda, Ph.D., R.N., an assistant professor at the University ... won a competitive grant from the Robert Wood Johnson ... for preventing teen dating violence among Hispanics. Gonzalez-Guarda is ... country to receive the three-year $350,000 Nurse Faculty Scholar ...
... News) -- Introducing powder-free latex gloves into health care facilities ... study shows. Researchers followed more than 800 health care ... tested the amount of latex allergen in the air ducts ... hospitals switched to powder-free latex gloves. There was a ...
... [Brown University] -- Thousands of college football players began competing ... of the new season comes new data on the risks ... backs and quarterbacks suffer the hardest hits to the head, ... often. The researchers measured head blows during games and practices ...
Cached Medicine News:Health News:Cheap drugs could save thousands of lives - in Sweden alone 2Health News:Global fight against non-communicable diseases should take lessons from HIV-AIDS 2Health News:Global fight against non-communicable diseases should take lessons from HIV-AIDS 3Health News:Extra Pounds a Deadly Risk Factor for Black Women: Study 2Health News:Extra Pounds a Deadly Risk Factor for Black Women: Study 3Health News:UM Gonzalez-Guarda wins grant from Robert Wood Johnson Foundation 2Health News:UM Gonzalez-Guarda wins grant from Robert Wood Johnson Foundation 3Health News:Switch to Powder-Free Latex Gloves Cuts Health Workers' Allergy Risk 2Health News:Running backs take hardest hits to the head, linemen take the most 2Health News:Running backs take hardest hits to the head, linemen take the most 3
(Date:1/15/2014)... , Jan. 15, 2014  Valeant Pharmaceuticals International, Inc. ... that the applicable waiting period under the Hart-Scott-Rodino Antitrust ... previously announced tender offer by its indirect wholly-owned subsidiary, ... shares of common stock of Solta Medical, Inc. (NASDAQ: ...
(Date:1/15/2014)... Ohio , Jan. 15, 2014  A novel wearable injector ... easy and painless for patients to self-inject prescription drugs in ... disorders, including cancer, blood diseases, autoimmune deficiencies, and genetic disorders.  ... to grow to $220B by 2018, according to analysts.   Many ...
(Date:1/14/2014)... , Jan. 14, 2014 The Brandeis Medical Center, led ... a premier and affordable laser tattoo removal experience with ... Brandeis, focus is in providing high quality cosmetic services with cutting ... " Southern California has seen a ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2
... 11 Nutri-Force Nutrition is proud to announce ... in Miami Lakes, Florida. This new facility was ... highly-valued customers with industry-leading quality and exceptionally efficient ... and innovative production control processes, the new facility ...
... and NEW YORK, Nov. 10 Inc. magazine has ... Inc. 5000 list of the fastest-growing private companies in the U.S. ... of the Top 100 Health Companies and No. 32 on the ... West Physics Consulting posted three-year revenue growth of 327.8% to ...
Cached Medicine Technology:West Physics Consulting Makes the 2009 Inc. 5000 List 2
Large, bright images from a bronchoscope designed for routine examination and treatment....
... the first in a series of bronchofiberscopes ... features necessary to meet the demand for ... scope includes a new control section and ... It also provides a wider field of ...
... Double lumen ... one-lung ventilation., ... Tube is packaged ... tube-to-circuit adaptors, suction ...
... Used for endobronchial blockade ... right lung for procedures ... The set consists of ... and an Arndt Multiport ...
Medicine Products: